EGFR tyrosine kinase inhibitors: a therapy for a few, for the majority or for all non-small cell lung cancer patients?

Giovanna Finocchiaro, Luca Toschi, Isabella Garassino, Fabio De Vincenzo, Elisabetta Campagnoli, Paolo Zucali, Raffaele Cavina, Giovanni L Ceresoli, Armando Santoro, Federico Cappuzzo
  • Expert Opinion on Medical Diagnostics, October 2007, Informa Healthcare
  • DOI: 10.1517/17530059.1.2.183

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/17530059.1.2.183

The following have contributed to this page: Dr Federico Cappuzzo